Umsetzung ASV-Rheuma

Rheuma-Management

Offizielles Mitteilungsorgan des BDRh e.V.

EULAR-Empfehlungen

Quelle: www.eular.org/index.cfm?framePage=/recommendations.cfm

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs  
Ann Rheum Dis Published Online First: 5 May 2010 doi:10.1136/ard.2009.126532

EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies  
Ann Rheum Dis. Published Online First: 5 November 2009. doi:10.1136/ard.2009.117200

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative
Ann Rheum Dis, Nov 2009; 68: 1680-1685

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Ann Rheum Dis, Feb 2010; 69: 325-331

Patients' and rheumatologists' perspectives on glucocorticoids an exercise to improve the implementation of the EULAR recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Ann Rheum Dis, Published Online First: 17 September 2009. doi:10.1136/ard.2009.114579

EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): Development of a consensus systemic disease activity index in primary Sjögren's syndrome  
Ann Rheum Dis, June 2010; 69: 1103-1109

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)  
Ann Rheum Dis, May 2009; 68: 620-628

EULAR recommendations for the management of Behçet disease
Ann Rheum Dis, Dec 2008, 67: 1656-1662

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists
Ann Rheum Dis, June 2008; 67: 782-788

EULAR evidence based recommendations for the management of fibromyalgia syndrome

Ann Rheum Dis, Apr 2008; 67: 536-541

EULAR recommendations for the management of systemic lupus erytematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including therapeutics (ESCISIT)
Ann Rheum Dis, Feb 2008; 67: 195-205.

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Ann Rheum Dis, Dec 2007; 66: 1560-1567. 

EULAR evidence based recommendations for the management of hand osteoarthritis - report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Ann Rheum Dis, Mar 2007; 66: 377 - 388.

EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Ann Rheum Dis, Jan 2007; 66: 34-45.

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Ann Rheum Dis, Oct 2006; 65: 1312 - 1324.

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

Ann Rheum Dis, Apr 2006; 65: 423 - 432.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Ann Rheum Dis, May 2005; 64: 669 - 681.

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Ann Rheum Dis, Dec 2003; 62: 1145 - 1155.

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Ann Rheum Dis, Dec 2000; 59: 936 - 944.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
Ann Rheum Dis., April 2009; 68: 470 - 476.